XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer
Clinical trial NCT01412294 · UNKNOWN
Trial details
- NCT number
- NCT01412294
- Sponsor
- Epidemiological and Clinical Research Information Network
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2017-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.